A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg/kg or 20 mg/kg
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Background: Ursodeoxycholic acid (UDCA) prolongs transplantation‐free survival in primary biliary cirrhosis (PBC). However, the optimal therapeutic dose has not been established. Aim: To compare the effects of UDCA administered in daily doses of 10 vs. 20 mg/kg on symptoms, liver biochemistry and biliary UDCA enrichment. Methods: A 6‐month multicentre randomized open controlled trial was conducted to assess the effects of an increase in the dose of UDCA to 20 mg/kg/day vs. continuation of 10 mg/kg/day for patients who had not achieved biochemical normalization during treatment for at least 6 months with the 10 mg/kg dose. Clinical and laboratory evaluations were performed at entry and at 3‐month intervals. The percentage UDCA in duodenal bile was assessed at entry and at 6 months. Results: Sixty‐one patients were enrolled. No side‐effects of UDCA were observed. Within the 20 mg/kg/day group significant decreases were found for alkaline phosphatase (− 8%; P = 0.003), aspartate aminotransferase (− 11%; P = 0.01), alanine aminotransferase (− 17%; P < 0.001), γ‐glutamyl transferase␣(− 34%; P < 0.001), immunoglobulin M (− 11%; P = 0.002) and cholesterol (− 8.1%; P < 0.001). In the 10 mg/kg group none of these parameters differed significantly from baseline. No significant differences between dose groups for symptom scores or serum bilirubin were found. Biliary enrichment with UDCA increased from 37% to 46% in the 20 mg/kg group (P = 0.02) while remaining stable in the 10 mg/kg group. Conclusions: Liver biochemistry improved in PBC patients receiving UDCA 20 mg/kg/day compared to a dose of 10 mg/kg/day. Both doses were equally well tolerated. These results indicate that UDCA 10 mg/kg/day is a suboptimal dose for treating PBC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poupon, R., Lindor, K., Cauch-Dudek, K., Dickson, E., Poupon, R., & Heathcote, E. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70183-5 · Cited by 648
Ursodiol for the Long-Term Treatment of Primary Biliary Cirrhosis
Poupon, R. E., Poupon, R., & Balkau, B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405123301903 · Cited by 497
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis
Lindor, K. D., Dickson, E. R., Baldus, W. P., Jorgensen, R. A., Ludwig, J., Murtaugh, P. A., Harrison, J. M., Wiesner, R. H., Anderson, M. L., Lange, S. M., et al. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90021-3 · Cited by 487
Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis
Lindor, K., Therneau, T., Jorgensen, R., Malinchoc, M., & Dickson, E. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8613058 · Cited by 228
Angulo, P., Dickson, E. R., Therneau, T. M., Jorgensen, R. A., Smith, C., DeSotel, C. K., Lange, S. M., Anderson, M. L., Mahoney, D. W., & Lindor, K. D. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80136-6 · Cited by 134
Research works printed but not linked: 42
- 10.1056/NEJM199611213352107 · DOI · Paper page
- Gershwin ME, 1995, The molecular basis of primary biliary cirrhosis: interfacing clinical medicine and wet bench research, Isr J Med Sci, 31, 22
- 10.1016/0002-9343(94)90187-2 · DOI
- 10.1002/hep.1840190512 · DOI · Paper page
- 10.1002/hep.1840220311 · doi:10.1002/hep.1840220311 · Paper page
- 10.1007/BF01536665 · DOI
- 10.1016/S0140-6736(87)91610-2 · DOI · Paper page
- 10.3109/00365529709000190 · DOI · Paper page
- 10.1016/S0168-8278(05)80214-4 · DOI
- 10.1111/j.1440-1746.1994.tb01237.x · DOI · Paper page
- 10.1016/0016-5085(89)91698-3 · DOI · Paper page
- 10.1016/0168-8278(95)80297-5 · DOI
- Taal BG, 1983, Clinical diagnosis of primary biliary cirrhosis: a classification based on major and minor criteria, Hepatogastroenterology, 30, 178
- 10.1002/bjs.1800600817 · DOI · Paper page
- Vonk RJ, 1986, Enterohepatic circulation in man. A simple method for the determination of duodenal bile acids, J Lipid Res, 27, 901, 10.1016/S0022-2275(20)38789-7 · doi:10.1016/s0022-2275(20)38789-7
- 10.1097/00005176-198504000-00021 · doi:10.1097/00005176-198504000-00021
- Turley SD, 1978, Re‐evaluation of the 3 alpha‐hydroxysteroid dehydrogenase assay for total bile acids in bile, J␣Lipid Res, 19, 924, 10.1016/S0022-2275(20)40709-6 · DOI · Paper page
- 10.1016/0009-8981(83)90070-0 · DOI · Paper page
- 10.1016/0005-2760(86)90044-5 · DOI
- Mitchell S, 1997, High dose ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC): Results after two years of a randomised double‐blind, placebo‐controlled trial, Gastroenterology, 112
- 10.3109/00365529709007686 · DOI · Paper page
- 10.1002/hep.1840160412 · DOI · Paper page
- 10.1002/hep.1840130222 · doi:10.1002/hep.1840130222
- 10.1016/0016-5085(92)90162-R · DOI
- 10.1016/0016-5085(86)90708-0 · DOI
- 10.1002/hep.1840040119 · DOI
- 10.1016/0016-5085(91)90603-I · DOI
- 10.1136/gut.36.6.935 · DOI · Paper page
- 10.1016/S0168-8278(96)80293-5 · DOI
- 10.1016/S0168-8278(95)80007-7 · DOI
- Muraca M, 1991, A simple method for the determination of lipid composition of human bile, J Lipid Res, 32, 371, 10.1016/S0022-2275(20)42097-8 · doi:10.1016/s0022-2275(20)42097-8
- 10.3109/00365529309103136 · doi:10.3109/00365529309103136
- 10.1136/gut.31.12.1407 · doi:10.1136/gut.31.12.1407
- Muraca M, 1994, Routine determination of biliary lipid composition with the entero‐test, Ann Chir, 48, 197
- 10.1002/hep.1840140609 · DOI · Paper page
- Batta AK, 1993, Effect of long‐term treatment with ursodiol on clinical and biochemical features and biliary bile acid metabolism in patients with primary biliary cirrhosis, Am J Gastroenterol, 88, 691
- 10.1016/0016-5085(91)90602-H · DOI · Paper page
- 10.1097/00042737-199707000-00011 · DOI
- 10.1016/0306-9877(86)90137-4 · DOI · Paper page
- 10.1016/0016-5085(93)90653-T · DOI · Paper page
- 10.1016/0016-5085(94)90027-2 · DOI
- 10.1016/0006-2952(90)90259-N · doi:10.1016/0006-2952(90)90259-n
Cited by
Hirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
Hirschfield, G. M., Dyson, J. K., Alexander, G. J. M., Chapman, M. H., Collier, J., Hübscher, S., Patanwala, I., Pereira, S. P., Thain, C., Thorburn, D., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315259 · Cited by 362
Ursodeoxycholic acid for primary biliary cirrhosis
Rudic, J. S., Poropat, G., Krstic, M. N., Bjelakovic, G., & Gluud, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000551.pub3 · Cited by 270
Sood, S., Gow, P. J., Christie, J. M., & Angus, P. W. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.064 · Cited by 140
Metadata
- Authors
- Hoogstraten, H. J. F. V., Smet, M. B. M. D., Renooij, Breed, Engels, Ouden‐Muller, J. W. D., Rijk, Smit, Zwertbroek, Hop, Henegouwen, G. P. V. B., Schalm, Buuren, H. R. V., & REPRESENTING THE DUTCH MULTICENTRE PBC STUDY GROUP
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 1998-10
- Volume
- 12
- Issue
- 10
- Pages
- 965-971
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2023786519
- Cited by
- 35
- References
- 5
- FWCI
- 2.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg/kg or 20 mg/kg. https://app.cochat.ai/papers/10.1046/j.1365-2036.1998.00395.x
- The paper
- Hoogstraten, H. J. F. V., Smet, M. B. M. D., Renooij, Breed, Engels, Ouden‐Muller, J. W. D., Rijk, Smit, Zwertbroek, Hop, Henegouwen, G. P. V. B., Schalm, Buuren, H. R. V., & REPRESENTING THE DUTCH MULTICENTRE PBC STUDY GROUP. (1998). A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg/kg or 20 mg/kg. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1046/j.1365-2036.1998.00395.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.